Amedisys Inc (NAS:AMED)
$ 91.23 0.21 (0.23%) Market Cap: 2.99 Bil Enterprise Value: 3.21 Bil PE Ratio: 36.20 PB Ratio: 2.60 GF Score: 85/100

Q3 2020 Amedisys Inc Earnings Call Transcript

Oct 29, 2020 / 03:00PM GMT
Release Date Price: $250.87 (+0.86%)
Operator

Greetings, and welcome to the Amedisys, Inc. Third Quarter 2020 Earnings Conference Call.

(Operator Instructions)

As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Mr. Nick Muscato, Senior Vice President of Finance. Thank you, sir. You may now begin.

Nick Muscato
Amedisys, Inc. - VP of Strategic Finance

Thank you, operator, and welcome to the Amedisys investor conference call to discuss the results of the third quarter ended September 30, 2020. A copy of our press release, supplemental slides and related Form 8-K filing with the SEC are available on the Investor Relations page of our website.

Speaking on today's call from Amedisys will be Paul Kusserow, Chairman, CEO and President; and Scott Ginn, Chief Financial Officer.

Also joining us is Chris Gerard, Chief Operating Officer; and Dave Kemmerly, Chief Legal and Government Affairs Officer.

Before we get started with our call, I would like to remind everyone that statements made on this conference call

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot